XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Option Plan (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Unit Activity
RSU activity under the Company's 2019 Plan is set forth below:
Number of
Shares
Weighted-
Average
Grant Date Fair Value
Outstanding, December 31, 20231,387,459 $4.24 
Awards granted1,287,225 $2.09 
Awards released(293,209)$5.87 
Awards canceled(571,007)$4.16 
Outstanding, September 30, 2024
1,810,468 $2.47 
Schedule of Stock Option Activity
Stock option activity under the 2019 Plan is set forth below:
 
Number of
Options
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value (in thousands)
Outstanding, December 31, 2023986,819 $11.87 6.44$228 
Granted55,500 $1.99 
Exercised(85,124)$0.26 
Forfeited(9,518)$16.70 
Expired(371,526)$15.48 
Outstanding, September 30, 2024
576,151 $10.23 6.57$197 
Vested and expected to vest, September 30, 2024
576,151 $10.23 6.57$197 
Options exercisable, September 30, 2024
552,686 $10.56 6.45$177 
Schedule of Non-Cash Stock-Based Compensation Expense
Total non-cash stock-based compensation expense recorded related to options granted, RSUs granted and stock purchase rights granted under the ESPP in the condensed statements of operations is as follows (in thousands):
 
 Three Months Ended September 30,Nine Months Ended September 30,
 2024202320242023
Costs of revenue$47 $45 $103 $161 
Selling, general and administrative114 792 1,058 2,497 
Research and development56 53 169 196 
Total$217 $890 $1,330 $2,854